Key facts
- It has raised $10.0M; the latest was Accelerator/Incubator ($10K) in May 2024.
- Notable investors include MedTech Innovator, Qualcomm Innovate in Taiwan Challenge, Taiwania Capital, TransPacific Venture Partners.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for APrevent Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for APrevent Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About APrevent Medical
Developer and manufacture of long-term implant system, speech conversion platform and other medical equipment designed for the treatment of speech disorders. The company offers minimally invasive and innovative ENT implant and Software-as-a-Service (SaaS) technologies for voice & speech disorders, enabling patients to improve voice and communication.
- Sector
- Healthcare
- HQ
- Taipei, Taiwan
- Founded
- 2013
- Website
- apreventmed.com/en
- Ownership
- Privately Held (backing)
APrevent Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in APrevent Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on APrevent Medical in its N-PORT filings yet. We sweep new filings monthly.